P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.
about
P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@en
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@nl
type
label
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@en
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@nl
prefLabel
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@en
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@nl
P2093
P2860
P1476
P-MAPA immunotherapy potentiat ...... ough targeting TLR4 signaling.
@en
P2093
Grazielle de Moura Ferreira
Iseu da Silva Nunes
Luiz Antonio Lupi
Luiz Gustavo de Almeida Chuffa
P2860
P2888
P356
10.1186/S13048-018-0380-5
P577
2018-01-17T00:00:00Z
P6179
1100465070